EP Patent

EP3750910A1 — Triterpenoids with hiv maturation inhibitory activity

Assigned to ViiV Healthcare UK No 4 Ltd · Expires 2020-12-16 · 5y expired

What this patent protects

Combinations of a compound according to formula Ia and an AIDS antiviral, immunomodulator, HIV entry inhibitor, anti-infective or vaccine. These combinations can be used in the treatment of HIV.

USPTO Abstract

Combinations of a compound according to formula Ia and an AIDS antiviral, immunomodulator, HIV entry inhibitor, anti-infective or vaccine. These combinations can be used in the treatment of HIV.

Drugs covered by this patent

fostemsavir-tromethamine (FOSTEMSAVIR TROMETHAMINE)

Patent Metadata

Patent number: EP3750910A1
Jurisdiction: EP
Classification: —
Expires: 2020-12-16
Drug substance claim: No
Drug product claim: No
Assignee: ViiV Healthcare UK No 4 Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.